Add My Company
Business Link: Click here to view the business
Confidentially offered for Sale
Ref Number: MC03-ABS
Asking Price: £300,000
Location: United Kingdom
Global Opportunity: 12m items used worldwide. Disposable with unique SP
Location: United Kingdom
Asking Price: Offers In Excess Of £300,000 + Royalties TBD.
Sales for Financial Year 2024: £233,000 p.a.
Investment Highlights:
- Extensive Research & Development: Over four years of R&D, resulting in a proven, effective medical device for cardiovascular intervention.
- Comprehensive Design & IPR: FDA approvals, US Patent (17 yrs remaining), EU Design Registration, Trademarks, ensuring a strong intellectual property position.
- Established Manufacturing: UK-based manufacturing with an existing customer base, currently producing and supplying approximately 1,300 units per month.
- Global Distribution: Distributor secured for the USA, Ireland and imminent M East distribution indicating international expansion potential.
Business Profile
Introduction: This is a unique opportunity to acquire a UK Limited company ("the Business") with all issued share capital. The Business has developed and patented a disposable medical device designed specifically for post cardiovascular interventions. The USP of the device is simplifying procedures and preservation of the radial artery, a critical component of modern cardiac care.
With a global shift towards accessing the heart via the radial artery rather than the femoral artery, this innovative device is positioned to meet increasing demand in a growing market. The product enhances procedures such as angiograms and angioplasties (Percutaneous Coronary Interventions, or PCI), which are conducted through radial artery access in the wrist.
Market Opportunity
The Business has identified a significant market opportunity due to the ongoing transition to radial artery procedures. Its device offers a superior solution for clinicians, providing enhanced ease of use, improved patient outcomes, and lower complication rates compared to other market options.
Full product details, along with in-depth market data, will be made available upon the completion of our Non-Disclosure Agreement (NDA).
Development and Collaboration
Since its inception, the Business has worked closely with leading medical professionals in the UK to perfect the design and functionality of the device.
The collaborative efforts with medical experts, designers, consultants, and manufacturers have resulted in a product that exceeds current market standards.
Production and Distribution
The Business operates UK-based manufacturing, supplying approximately 1,300 units per month to an existing customer base.
Regulatory Approvals and Certifications
All essential regulatory approvals and certifications are in place, including:
- FDA Registration: Approved and registered with a licensed US agent, distribution in the US and M East. USA being significantly the highest value potential ie >1m unit sales potential at higher than (UK or EU) prices.
Intellectual Property and Patents
The Business holds all necessary Trademarks and Intellectual Property Rights (IPR), ensuring protection of its innovative design and safeguarding its competitive advantage. This strong IP position provides an excellent platform for growth and expansion.
Growth Potential
The device’s clinical efficacy and ease of use, combined with the increasing trend toward radial artery procedures, make it ideally positioned for massive growth potential. Opportunities for expansion include:
- Global Distribution Network: The potential to establish further distribution agreements across Europe, Asia, and other regions with high rates of PCI procedures.
- Product Line Extension: Developing additional devices for complementary cardiovascular procedures.
Financial Summary
Details regarding the company’s financial performance, including revenue, profitability, and forecasts, are available upon request and the signing of a Non-Disclosure Agreement.
Conclusion
This is an exceptional opportunity to acquire a pioneering business in the medical device sector, with a fully developed product, robust IP protection, and international market readiness. With the ongoing shift towards radial artery access procedures and the Business’s solid foundation of regulatory approvals and manufacturing capabilities, significant growth potential awaits in the global cardiovascular intervention market.
Interested parties are invited to contact us for further details and to arrange a confidential discussion.
Next Step : To Register Interest, you will need to fully complete our Confidentiality Agreement form (NDA).
To Register Interest or to seek additional Information, please contact Abercorn Business Sales e-mail: expert@abercornbusinesssales.com or telephone: 0800-246-1313
Commercial Finance:
Abercorn Business Sales are specialists in highly confidential off-market business sales. Should you require commercial finance, we have a panel of leading commercial finance brokers with access to the whole market to enable you to source the best possible terms.
Call today on 0800-246-1313 or email at expert@abercornbusinesssales.com or visit our website www.abercornbusinesssales.com
Attention Business Owners. We are always in search of quality buyers waiting for you, so if you are thinking of selling your business or would like to acquire another business, please email us to discover the difference that is Abercorn Business Brokers.
For more information on MC03-ABS - Innovative Medical Device UK Company for Sale talk to Abercorn Business Sales